Ignite Creation Date:
2024-05-06 @ 3:37 AM
Last Modification Date:
2024-10-26 @ 11:36 AM
Study NCT ID:
NCT02336347
Status:
COMPLETED
Last Update Posted:
2015-07-13
First Post:
2015-01-08
Brief Title:
A Phase 1 Study Comparing AVP-786 With AVP-923
Sponsor:
Avanir Pharmaceuticals
Organization:
Avanir Pharmaceuticals
Study Overview
Official Title:
A Phase 1 Single-center Randomized Double-blind Double-dummy 2-way Crossover Study Comparing AVP-786 With AVP-923
Status:
COMPLETED
Status Verified Date:
2015-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To compare pharmacokinetics PK of AVP-786 deuterated d6 dextromethorphan hydrobromide d6-DMquinidine sulfate Q to AVP-923 dextromethorphan hydrobromide DMQ at steady state
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None